Contact
searchSearch
HMP Global

Psoriatic Arthritis

Featured Article

News
Managing Treatment Burden in PsA and RA: Patients' Views on Methotrexate and TNFi Use
12/15/2023
Hannah Musick
“Patients experience a wide range of burden associated with treatments used for PsA and RA,” said researchers.
“Patients experience a wide range of burden associated with treatments used for PsA and RA,” said researchers.
“Patients experience a wide...
12/15/2023
First Report Managed Care
News
Bimekizumab is Safe and Effective in Treating Patients With Psoriatic Arthritis Native to Biologic Treatment, Study Finds
11/15/2023
Lisa Kuhns, PhD, MD
At week 16, 44% of patients receiving bimekizumab met the primary endpoint of 50% improvement in the American College of Rheumatology response criteria (ACR50) compared with 10% of those receiving placebo.
At week 16, 44% of patients receiving bimekizumab met the primary endpoint of 50% improvement in the American College of Rheumatology response criteria (ACR50) compared with 10% of those receiving placebo.
At week 16, 44% of patients...
11/15/2023
First Report Managed Care
News
Early Detection Tool for Psoriatic Arthritis in Psoriasis Patients
10/24/2023
Danielle Sposato
The model demonstrates good performance, which can be adjusted based on its intended use, such as screening or targeting high-risk individuals for intervention. This tool can potentially prevent the progression from psoriasis to PsA by...
The model demonstrates good performance, which can be adjusted based on its intended use, such as screening or targeting high-risk individuals for intervention. This tool can potentially prevent the progression from psoriasis to PsA by...
The model demonstrates good...
10/24/2023
First Report Managed Care
News
Persistence, Switching in Patients With PsA Similar With Ixekizumab and Secukinumab
09/12/2023
Jolynn Tumolo
Researchers found that real-world treatment patterns and use of adjunctive pain and anti-inflammatory medications may be similar in patients with PsA initiating ixekizumab and secukinumab. 
Researchers found that real-world treatment patterns and use of adjunctive pain and anti-inflammatory medications may be similar in patients with PsA initiating ixekizumab and secukinumab. 
Researchers found that...
09/12/2023
First Report Managed Care
News
New and Previous Chronic Inflammatory Disease Diagnoses Increases Treatment Costs
08/22/2023
Jolynn Tumolo
Newly-diagnosed patients with chronic inflammatory diseases previously diagnosed with psoriasis, psoriatic arthritis, axial spondyloarthritis, or hidradenitis suppurative experienced increased treatment costs the year after diagnosis.
Newly-diagnosed patients with chronic inflammatory diseases previously diagnosed with psoriasis, psoriatic arthritis, axial spondyloarthritis, or hidradenitis suppurative experienced increased treatment costs the year after diagnosis.
Newly-diagnosed patients with...
08/22/2023
First Report Managed Care
News
Cardiometabolic, Mental Health Disorders Common in Patients With PsA
07/27/2023
Jolynn Tumolo
"Future studies are needed for a better understanding of the pathogenic mechanisms of, and the development of better protocols for the identification and treatment of patients with, comorbidities in patients with PsA," said researchers. 
"Future studies are needed for a better understanding of the pathogenic mechanisms of, and the development of better protocols for the identification and treatment of patients with, comorbidities in patients with PsA," said researchers. 
"Future studies are needed for a...
07/27/2023
First Report Managed Care
News
Sleep Problems Common Among Patients With Psoriatic Arthritis
06/16/2023
Jolynn Tumolo
A new meta-analysis reveals that the prevalence of poor sleep quality among patients with psoriatic arthritis is 72.9%, significantly higher than in healthy controls.
A new meta-analysis reveals that the prevalence of poor sleep quality among patients with psoriatic arthritis is 72.9%, significantly higher than in healthy controls.
A new meta-analysis reveals that...
06/16/2023
First Report Managed Care
News
Synovio-Enthesitis on Ultrasound May Detect Subclinical PsA
05/18/2023
Jolynn Tumolo
“Routine ultrasound evaluation could help screen [patients with psoriasis] in the subclinical psoriatic arthritis phase,” wrote the research team.
“Routine ultrasound evaluation could help screen [patients with psoriasis] in the subclinical psoriatic arthritis phase,” wrote the research team.
“Routine ultrasound evaluation...
05/18/2023
First Report Managed Care
News
JAK Inhibitor Improves Symptoms in Patients With Psoriatic Arthritis and Axial Involvement
04/21/2023
Jolynn Tumolo
In two phase 3 studies comparing upadacitinib to placebo and adalimumab, upadacitinib improved symptoms in patients with psoriatic arthritis and axial involvement.
In two phase 3 studies comparing upadacitinib to placebo and adalimumab, upadacitinib improved symptoms in patients with psoriatic arthritis and axial involvement.
In two phase 3 studies comparing...
04/21/2023
First Report Managed Care
News
IL-23 Inhibitors Outperform Placebo for Treatment of Psoriatic Arthritis, Meta-Analysis Shows
03/16/2023
Jolynn Tumolo
“IL-23 inhibitors have the potential to be a promising therapeutic option, especially for...patients who have an insufficient response to conventional synthetic disease-modifying antirheumatic drugs,” researchers wrote.
“IL-23 inhibitors have the potential to be a promising therapeutic option, especially for...patients who have an insufficient response to conventional synthetic disease-modifying antirheumatic drugs,” researchers wrote.
“IL-23 inhibitors have the...
03/16/2023
First Report Managed Care
News
IL-17A Inhibition With Treatment Improves Symptoms of Psoriatic Arthritis
10/27/2022
Edan Stanley
Utilizing Power Doppler ultrasound, researchers examined the dynamics of response of synovitis to IL-17A inhibition with secukinumab in patients with active psoriatic arthritis.
Utilizing Power Doppler ultrasound, researchers examined the dynamics of response of synovitis to IL-17A inhibition with secukinumab in patients with active psoriatic arthritis.
Utilizing Power Doppler...
10/27/2022
First Report Managed Care

Newsfeed

News
Managing Treatment Burden in PsA and RA: Patients' Views on Methotrexate and TNFi Use
12/15/2023
Hannah Musick
“Patients experience a wide range of burden associated with treatments used for PsA and RA,” said researchers.
“Patients experience a wide range of burden associated with treatments used for PsA and RA,” said researchers.
“Patients experience a wide...
12/15/2023
First Report Managed Care
News
Bimekizumab is Safe and Effective in Treating Patients With Psoriatic Arthritis Native to Biologic Treatment, Study Finds
11/15/2023
Lisa Kuhns, PhD, MD
At week 16, 44% of patients receiving bimekizumab met the primary endpoint of 50% improvement in the American College of Rheumatology response criteria (ACR50) compared with 10% of those receiving placebo.
At week 16, 44% of patients receiving bimekizumab met the primary endpoint of 50% improvement in the American College of Rheumatology response criteria (ACR50) compared with 10% of those receiving placebo.
At week 16, 44% of patients...
11/15/2023
First Report Managed Care
News
Early Detection Tool for Psoriatic Arthritis in Psoriasis Patients
10/24/2023
Danielle Sposato
The model demonstrates good performance, which can be adjusted based on its intended use, such as screening or targeting high-risk individuals for intervention. This tool can potentially prevent the progression from psoriasis to PsA by...
The model demonstrates good performance, which can be adjusted based on its intended use, such as screening or targeting high-risk individuals for intervention. This tool can potentially prevent the progression from psoriasis to PsA by...
The model demonstrates good...
10/24/2023
First Report Managed Care
News
Persistence, Switching in Patients With PsA Similar With Ixekizumab and Secukinumab
09/12/2023
Jolynn Tumolo
Researchers found that real-world treatment patterns and use of adjunctive pain and anti-inflammatory medications may be similar in patients with PsA initiating ixekizumab and secukinumab. 
Researchers found that real-world treatment patterns and use of adjunctive pain and anti-inflammatory medications may be similar in patients with PsA initiating ixekizumab and secukinumab. 
Researchers found that...
09/12/2023
First Report Managed Care
News
New and Previous Chronic Inflammatory Disease Diagnoses Increases Treatment Costs
08/22/2023
Jolynn Tumolo
Newly-diagnosed patients with chronic inflammatory diseases previously diagnosed with psoriasis, psoriatic arthritis, axial spondyloarthritis, or hidradenitis suppurative experienced increased treatment costs the year after diagnosis.
Newly-diagnosed patients with chronic inflammatory diseases previously diagnosed with psoriasis, psoriatic arthritis, axial spondyloarthritis, or hidradenitis suppurative experienced increased treatment costs the year after diagnosis.
Newly-diagnosed patients with...
08/22/2023
First Report Managed Care
News
Cardiometabolic, Mental Health Disorders Common in Patients With PsA
07/27/2023
Jolynn Tumolo
"Future studies are needed for a better understanding of the pathogenic mechanisms of, and the development of better protocols for the identification and treatment of patients with, comorbidities in patients with PsA," said researchers. 
"Future studies are needed for a better understanding of the pathogenic mechanisms of, and the development of better protocols for the identification and treatment of patients with, comorbidities in patients with PsA," said researchers. 
"Future studies are needed for a...
07/27/2023
First Report Managed Care
News
Sleep Problems Common Among Patients With Psoriatic Arthritis
06/16/2023
Jolynn Tumolo
A new meta-analysis reveals that the prevalence of poor sleep quality among patients with psoriatic arthritis is 72.9%, significantly higher than in healthy controls.
A new meta-analysis reveals that the prevalence of poor sleep quality among patients with psoriatic arthritis is 72.9%, significantly higher than in healthy controls.
A new meta-analysis reveals that...
06/16/2023
First Report Managed Care
News
Synovio-Enthesitis on Ultrasound May Detect Subclinical PsA
05/18/2023
Jolynn Tumolo
“Routine ultrasound evaluation could help screen [patients with psoriasis] in the subclinical psoriatic arthritis phase,” wrote the research team.
“Routine ultrasound evaluation could help screen [patients with psoriasis] in the subclinical psoriatic arthritis phase,” wrote the research team.
“Routine ultrasound evaluation...
05/18/2023
First Report Managed Care
News
JAK Inhibitor Improves Symptoms in Patients With Psoriatic Arthritis and Axial Involvement
04/21/2023
Jolynn Tumolo
In two phase 3 studies comparing upadacitinib to placebo and adalimumab, upadacitinib improved symptoms in patients with psoriatic arthritis and axial involvement.
In two phase 3 studies comparing upadacitinib to placebo and adalimumab, upadacitinib improved symptoms in patients with psoriatic arthritis and axial involvement.
In two phase 3 studies comparing...
04/21/2023
First Report Managed Care
News
IL-23 Inhibitors Outperform Placebo for Treatment of Psoriatic Arthritis, Meta-Analysis Shows
03/16/2023
Jolynn Tumolo
“IL-23 inhibitors have the potential to be a promising therapeutic option, especially for...patients who have an insufficient response to conventional synthetic disease-modifying antirheumatic drugs,” researchers wrote.
“IL-23 inhibitors have the potential to be a promising therapeutic option, especially for...patients who have an insufficient response to conventional synthetic disease-modifying antirheumatic drugs,” researchers wrote.
“IL-23 inhibitors have the...
03/16/2023
First Report Managed Care
Behind the Bill
CMS Expands Oversight and Competition Among Organ Procurement Organizations
11/06/2026
Grace Taylor, MS, MA
New Centers for Medicare & Medicaid Services (CMS) requirements address organ procurement safety, performance measurement, and service-area transitions, with implications for transplant access and care coordination.
New Centers for Medicare & Medicaid Services (CMS) requirements address organ procurement safety, performance measurement, and service-area transitions, with implications for transplant access and care coordination.
New Centers for Medicare &...
11/06/2026
First Report Managed Care
News
MASH Treatment Model Projects Significant Economic Wastage With Low Semaglutide Persistence
11/06/2026
Rebecca Amrick
A study presented at AASLD TLM 2026 found that low adherence to optimal-dose semaglutide among patients with metabolic dysfunction-associated steatohepatitis (MASH) was projected to contribute to significant excess medical and pharmacy costs...
A study presented at AASLD TLM 2026 found that low adherence to optimal-dose semaglutide among patients with metabolic dysfunction-associated steatohepatitis (MASH) was projected to contribute to significant excess medical and pharmacy costs...
A study presented at AASLD TLM...
11/06/2026
First Report Managed Care
News
MASH Disease Progression Associated With Increased Economic Burden Among Medicare Beneficiaries
11/04/2026
Rebecca Amrick
A study of Medicare fee-for-service beneficiaries found that those with metabolic dysfunction-associated steatohepatitis (MASH) had higher health care utilization rates and medical costs compared to those without MASH, with the greatest...
A study of Medicare fee-for-service beneficiaries found that those with metabolic dysfunction-associated steatohepatitis (MASH) had higher health care utilization rates and medical costs compared to those without MASH, with the greatest...
A study of Medicare...
11/04/2026
First Report Managed Care
News
Real-World Evidence Highlights Broader Benefits of Omalizumab for Food Allergy Management
11/03/2026
Hannah Musick
A narrative review of real-world evidence suggests that omalizumab may improve food allergy management beyond preventing allergic reactions, with potential benefits for dietary flexibility, quality of life, and patients with complex allergic...
A narrative review of real-world evidence suggests that omalizumab may improve food allergy management beyond preventing allergic reactions, with potential benefits for dietary flexibility, quality of life, and patients with complex allergic...
A narrative review of real-world...
11/03/2026
First Report Managed Care
News
Direct Patient and Caregiver Engagement in Prior Authorization Linked to Care Delays
11/03/2026
Rebecca Amrick
Researchers found that direct patient and caregiver involvement in prior authorization procedures was associated with delayed or suboptimal care, highlighting the need for policy reform to reduce administrative burdens and improve access to...
Researchers found that direct patient and caregiver involvement in prior authorization procedures was associated with delayed or suboptimal care, highlighting the need for policy reform to reduce administrative burdens and improve access to...
Researchers found that direct...
11/03/2026
First Report Managed Care
Behind the Bill
HHS HTI-5 Final Rule Cuts Health IT Requirements With $1.5 Billion in Projected Savings
10/30/2026
Grace Taylor, MS, MA
The US Department of Health and Human Services’ (HHS) Health Data, Technology, and Interoperability (HTI-5) final rule reduces health IT certification requirements and projects substantial regulatory savings while leaving proposed...
The US Department of Health and Human Services’ (HHS) Health Data, Technology, and Interoperability (HTI-5) final rule reduces health IT certification requirements and projects substantial regulatory savings while leaving proposed...
The US Department of Health and...
10/30/2026
First Report Managed Care
News
Suboptimal TKI Adherence Across Payer Types Among Patients With CML
10/30/2026
Rebecca Amrick
A comparison of insurance types showed that tyrosine kinase inhibitor (TKI) approval for patients with chronic myeloid leukemia (CML) was higher among Medicare and Medicaid beneficiaries, but treatment adherence remained suboptimal across...
A comparison of insurance types showed that tyrosine kinase inhibitor (TKI) approval for patients with chronic myeloid leukemia (CML) was higher among Medicare and Medicaid beneficiaries, but treatment adherence remained suboptimal across...
A comparison of insurance types...
10/30/2026
First Report Managed Care
News
Real-World Study Reveals Shifting Treatment Patterns and Persistent Unmet Needs in DLBCL
10/29/2026
Hannah Musick
A real-world US study found that novel therapies are increasingly replacing conventional treatments for diffuse large B-cell lymphoma (DLBCL), although declining survival outcomes across successive lines of therapy and substantial variation...
A real-world US study found that novel therapies are increasingly replacing conventional treatments for diffuse large B-cell lymphoma (DLBCL), although declining survival outcomes across successive lines of therapy and substantial variation...
A real-world US study found that...
10/29/2026
First Report Managed Care
News
Inadequate Hematocrit Control in Polycythemia Vera Linked to High Health Care Burden
10/29/2026
Grace Taylor, MS, MA
A US claims study found that patients with polycythemia vera frequently experienced inadequate hematocrit control despite treatment, with thromboembolic events contributing to substantial health care costs.
A US claims study found that patients with polycythemia vera frequently experienced inadequate hematocrit control despite treatment, with thromboembolic events contributing to substantial health care costs.
A US claims study found that...
10/29/2026
First Report Managed Care
News
MA Associated With Less Expensive Cancer Therapies but Similar Treatment Utilization Compared to TM
10/28/2026
Rebecca Amrick
Researchers found that while Medicare Advantage (MA) is associated with lower-cost cancer treatments, beneficiaries had a similar likelihood of initiating optimal treatments for cancer type as those enrolled in traditional Medicare (TM).
Researchers found that while Medicare Advantage (MA) is associated with lower-cost cancer treatments, beneficiaries had a similar likelihood of initiating optimal treatments for cancer type as those enrolled in traditional Medicare (TM).
Researchers found that while...
10/28/2026
First Report Managed Care

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use